Cynthia Bernier

772 total citations
8 papers, 200 citations indexed

About

Cynthia Bernier is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Cynthia Bernier has authored 8 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Physiology. Recurrent topics in Cynthia Bernier's work include Calcium signaling and nucleotide metabolism (3 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Biochemical and Molecular Research (2 papers). Cynthia Bernier is often cited by papers focused on Calcium signaling and nucleotide metabolism (3 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Biochemical and Molecular Research (2 papers). Cynthia Bernier collaborates with scholars based in Canada, France and Taiwan. Cynthia Bernier's co-authors include Anne Roulston, Marc Lussier, Marie St‐Hilaire, Guylain Boulay, Maxime Pinard, Nancy Francoeur, Gordon C. Shore, Dominique Bédard, Pierre Beauparlant and Michel‐Olivier Gratton and has published in prestigious journals such as Journal of Biological Chemistry, Cell Reports and Oncotarget.

In The Last Decade

Cynthia Bernier

8 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cynthia Bernier Canada 6 105 72 44 40 29 8 200
Rachel Tang Germany 8 143 1.4× 31 0.4× 42 1.0× 6 0.1× 35 1.2× 9 284
Alfredo Sagredo Chile 7 188 1.8× 23 0.3× 72 1.6× 6 0.1× 23 0.8× 11 296
Clay Wakano United States 8 218 2.1× 36 0.5× 116 2.6× 3 0.1× 8 0.3× 12 379
Judit Márton Hungary 8 130 1.2× 119 1.7× 4 0.1× 24 0.6× 26 0.9× 12 262
Cristina P. da Silva Germany 8 150 1.4× 39 0.5× 227 5.2× 15 0.4× 17 0.6× 8 448
Ali Naji United States 8 159 1.5× 33 0.5× 24 0.5× 2 0.1× 11 0.4× 11 268
Pascale Adami France 12 209 2.0× 26 0.4× 4 0.1× 9 0.2× 60 2.1× 22 339
Julia S. Samaddar United States 4 209 2.0× 55 0.8× 4 0.1× 48 1.2× 208 7.2× 4 346
Taylor K. Loe United States 6 196 1.9× 35 0.5× 2 0.0× 62 1.6× 41 1.4× 8 321
Qinrui Wang China 6 99 0.9× 15 0.2× 25 0.6× 2 0.1× 18 0.6× 11 166

Countries citing papers authored by Cynthia Bernier

Since Specialization
Citations

This map shows the geographic impact of Cynthia Bernier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia Bernier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia Bernier more than expected).

Fields of papers citing papers by Cynthia Bernier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cynthia Bernier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia Bernier. The network helps show where Cynthia Bernier may publish in the future.

Co-authorship network of co-authors of Cynthia Bernier

This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia Bernier. A scholar is included among the top collaborators of Cynthia Bernier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia Bernier. Cynthia Bernier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Zimmermann, Michal, Cynthia Bernier, Sara Fournier, et al.. (2022). Guiding ATR and PARP inhibitor combinations with chemogenomic screens. Cell Reports. 40(2). 111081–111081. 34 indexed citations
2.
Bernier, Cynthia, Michel Gravel, Matthew Dankner, et al.. (2018). DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy. Anti-Cancer Drugs. 29(8). 774–785. 16 indexed citations
3.
Veyrac, G., et al.. (2018). Œdèmes palpébraux : un effet indésirable rare des inhibiteurs de protéasome. Annales de Dermatologie et de Vénéréologie. 145(12). S153–S153. 1 indexed citations
4.
Cole, Jonathan, Marie‐Christine Guiot, Michel Gravel, et al.. (2017). Novel NAPRT specific antibody identifies small cell lung cancer and neuronal cancers as promising clinical indications for a NAMPT inhibitor/niacin co-administration strategy. Oncotarget. 8(44). 77846–77859. 15 indexed citations
5.
Nguyen, Mai, Regina Cencic, Cynthia Bernier, et al.. (2015). Obatoclax is a direct and potent antagonist of membrane-restricted Mcl-1 and is synthetic lethal with treatment that induces Bim. BMC Cancer. 15(1). 568–568. 16 indexed citations
6.
Beauparlant, Pierre, Dominique Bédard, Cynthia Bernier, et al.. (2009). Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777. Anti-Cancer Drugs. 20(5). 346–354. 51 indexed citations
7.
Roulston, Anne, Mark H. Watson, Cynthia Bernier, et al.. (2007). GMX1777: a novel inhibitor of NAD+ biosynthesis via inhibition of nicotinamide phosphoribosyl transferase.. Molecular Cancer Therapeutics. 6. 2 indexed citations
8.
Lussier, Marc, Cynthia Bernier, Nancy Francoeur, et al.. (2005). MxA, a Member of the Dynamin Superfamily, Interacts with the Ankyrin-like Repeat Domain of TRPC. Journal of Biological Chemistry. 280(19). 19393–19400. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026